Healthcare provider profile · identity verified

Pearlie Lim, MD

Family Practice · ANAHEIM, CA · NPI 1154479061

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	503	218
Amlodipine Besylate	Amlodipine Besylate	275	110
Levothyroxine Sodium	Levothyroxine Sodium	218	85
Losartan Potassium	Losartan Potassium	215	92
Lisinopril	Lisinopril	177	83
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	163	69
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	146	53
Rosuvastatin Calcium	Rosuvastatin Calcium	140	73
Albuterol Sulfate Hfa	Albuterol Sulfate	127	70
Atenolol	Atenolol	127	49
Simvastatin	Simvastatin	112	46
Alendronate Sodium	Alendronate Sodium	105	44
Meloxicam	Meloxicam	101	54
Trazodone Hcl	Trazodone Hcl	98	29
Metoprolol Tartrate	Metoprolol Tartrate	92	38
Omeprazole	Omeprazole	92	46
Metformin Hcl	Metformin Hcl	86	43
Metformin Hcl Er	Metformin Hcl	84	40
Gabapentin	Gabapentin	75	27
Pradaxa	Dabigatran Etexilate Mesylate	71	27
Glipizide	Glipizide	70	33
Terazosin Hcl	Terazosin Hcl	70	24
Potassium Chloride	Potassium Chloride	64	34
Hydrochlorothiazide	Hydrochlorothiazide	63	29
Fluoxetine Hcl	Fluoxetine Hcl	60	25
Tramadol Hcl	Tramadol Hcl	56	20
Azelastine Hcl	Azelastine Hcl	54	20
Pantoprazole Sodium	Pantoprazole Sodium	53	26
Alvesco	Ciclesonide	51	38
Alprazolam	Alprazolam	44	12
Ozempic	Semaglutide	43	suppressed
Ropinirole Hcl	Ropinirole Hcl	43	11
Triamcinolone Acetonide	Triamcinolone Acetonide	43	29
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	41	11
Tamsulosin Hcl	Tamsulosin Hcl	41	26
Furosemide	Furosemide	40	21
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	39	14
Prednisone	Prednisone	38	33
Duloxetine Hcl	Duloxetine Hcl	37	16
Ibuprofen	Ibuprofen	37	20
Allopurinol	Allopurinol	35	16
Cefadroxil	Cefadroxil	34	31
Sertraline Hcl	Sertraline Hcl	33	17
Bupropion Xl	Bupropion Hcl	31	16
Humulin N Kwikpen	Insulin Nph Human Isophane	31	12
Cephalexin	Cephalexin	29	27
Finasteride	Finasteride	29	13
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	27	27
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	12
Ondansetron Odt	Ondansetron	25	12
Trospium Chloride	Trospium Chloride	25	12
Clobetasol Propionate	Clobetasol Propionate	24	16
Montelukast Sodium	Montelukast Sodium	24	suppressed
Clopidogrel	Clopidogrel Bisulfate	23	12
Doxycycline Monohydrate	Doxycycline Monohydrate	22	22
Metoprolol Succinate	Metoprolol Succinate	22	suppressed
Donepezil Hcl	Donepezil Hcl	21	suppressed
Raloxifene Hcl	Raloxifene Hcl	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Famotidine	Famotidine	20	12
Jardiance	Empagliflozin	20	suppressed
Lactulose	Lactulose	20	13
Morphine Sulfate Er	Morphine Sulfate	20	suppressed
Pravastatin Sodium	Pravastatin Sodium	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	19
Bisoprolol Fumarate	Bisoprolol Fumarate	19	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	13
Metronidazole	Metronidazole	19	15
Estradiol	Estradiol	18	suppressed
Fenofibrate	Fenofibrate	18	suppressed
Hydrocortisone	Hydrocortisone	18	12
Lorazepam	Lorazepam	18	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	18	suppressed
Acyclovir	Acyclovir	16	suppressed
Carvedilol	Carvedilol	16	suppressed
Temazepam	Temazepam	16	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	15	15
Chlorthalidone	Chlorthalidone	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	12
Ipratropium Bromide	Ipratropium Bromide	14	suppressed
Eliquis	Apixaban	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Nystatin	Nystatin	13	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Humulin N	Insulin Nph Human Isophane	12	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Amoxicillin	Amoxicillin	11	suppressed
Citalopram Hbr	Citalopram Hydrobromide	11	suppressed
Ezetimibe	Ezetimibe	11	suppressed
Fluconazole	Fluconazole	11	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error